MarginsXMarginsX
Home › Markets › Health Care › CLNN

Clene Inc. (CLNN)

CLNN trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$3.66
-6.63% on the day
Market cap
$52.7M
Micro cap
Revenue · 2025
$200K
-41.5% on 2024
Net income · 2025
-$26.2M
-13086.5% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:Revenues), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1822791/000143774926008502/0001437749-26-008502-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerCLNN on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryUnited States
IPO yearNot reported by the screener
SEC CIK0001822791
SEC industry codePharmaceutical Preparations
Incorporated inDE

Financials · 2025

LineValue
Revenue$200K
Net income-$26.2M
Operating income-$23.1M
Net margin-13086.5%
Operating margin-11541.5%
Revenue growth-41.5%
Cash$5.2M
Total assets$18.1M
P/E (computed)Net income was not positive
P/S (computed)263.5×

Warning signs

Cash runway
7.2 months
$9.9M cash at September 30, 2026
Share count, 1 year
+39.3%
2025-11-10 to 2026-11-02 · +124.3% over 3 years
Going-concern doubt
Yes
10-Q filed November 4, 2026
Insider net buying, 12 months
-$5.6M
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"These conditions raise substantial doubt about the Company's ability to continue as a going concern."
10-Q 2026-11-04
Cash and burn$9.9M cash; operating cash flow -$4.1M a quarter.Report 2026-09-30
Shares outstanding14,400,175 (2026-11-02); 10,333,980 a year earlier; 128,415,605 three years earlier. 3y figure adjusted for split (1-for-20 overall).Cover page 2026-11-02
Reverse splits, 3 years1; latest 1-for-20 on 2024-07-11Source 2024-07-11
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 4 424B5 takedowns, 4 at the marketLatest 2026-09-16
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
Delisting25-NSE filed25-NSE 2025-12-30
AuditorDeloitte & Touche LLP, Salt Lake City, Utah, United StatesPCAOB Form AP 2026-03-30
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $217K, sold $5.8M on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$56K$3.9M-$4.6M$9.9M$17.5M$238K10-Q 2026-11-04
Q2 2026
2026-06-30
$90K-$13.4M-$2.6M$9.7M$17.6M$197K10-Q 2026-08-14
Q1 2026
2026-03-31
$15K-$8.1M-$4.5M$5.9M$17.7M$134K10-Q 2026-05-14
Q4 2025
2025-12-31
$77K-$9.2M-$4.8M$5.2M$17.8M$200K10-K 2026-03-17
Q3 2025
2025-09-30
$15K-$8.8M-$4.0M$7.9M$17.9M$214K10-Q 2026-11-04
Q2 2025
2025-06-30
$27K-$7.4M-$4.7M$7.3M$16.5M$286K10-Q 2026-08-14
Q1 2025
2025-03-31
$81K-$751K-$5.0M$9.8M$16.6M$350K10-Q 2026-05-14
Q4 2024
2024-12-31
$91K-$13.5M-$4.9M$12.2M$11.2M$342K10-K 2026-03-17

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document
FORM 424B5
424B52026-09-16
Latest annual report
FORM 10-K
10-K2026-03-17
Latest quarterly / interim
FORM 10-Q
10-Q2026-11-04
Latest current report
FORM 8-K
8-K2026-11-04
Latest proxy
FORM DEFA14A
DEFA14A2026-04-10

Source: SEC EDGAR submissions feed, 715 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-0.8%
1 month+15.6%
3 months-6.4%
Year to date-33.2%
1 year-46.3%
From 52-week high-62.2%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
APLMApollomics Inc.$17.84+0.91%$51.7M
SDEVStablecoin Development Corporation$0.7055-9.55%$51.6M
HRTXHeron Therapeutics Inc.$0.2843-8.44%$54.1M
XLOXilio Therapeutics Inc.$7.70-3.08%$54.4M
QUCYQuantum Cyber N.V.$0.5850-7.58%$51.0M
AZRAzora Therapeutics Inc.$3.81-6.85%$54.4M
INCRIntercure Ltd.$3.63-4.22%$54.5M
CINGCingulate Inc.$3.75-12.79%$54.5M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier